Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 23

Results For "disease"

3223 News Found

KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru
Hospitals | June 23, 2026

KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru

KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,


FDA advisory panel backs Moderna flu vaccine candidate for older adults
News | June 23, 2026

FDA advisory panel backs Moderna flu vaccine candidate for older adults

The backing comes as influenza remains a persistent public health burden


Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results
News | June 23, 2026

Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results

The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines


ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward
Technology | June 23, 2026

ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward

The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows


QMS Medical targets Rs. 500 crore revenue by FY29
Healthcare | June 23, 2026

QMS Medical targets Rs. 500 crore revenue by FY29

The company reported consolidated revenue of Rs. 172.9 crore and EBITDA of Rs 25.9 crore in FY26


BioMed X and Biogen launch global neuroimmunology research challenge
R&D | June 23, 2026

BioMed X and Biogen launch global neuroimmunology research challenge

Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets


71% of Indians targeted by health scams amid rise of AI-generated misinformation: McAfee study
Healthcare | June 23, 2026

71% of Indians targeted by health scams amid rise of AI-generated misinformation: McAfee study

Social media emerges as the primary channel for health-related scams, while influencer endorsements and AI-generated content amplify risks for consumers


Pfizer lung cancer drug misses key survival goal in Phase 3 trial
Clinical Trials | June 23, 2026

Pfizer lung cancer drug misses key survival goal in Phase 3 trial

The company said the safety profile remained consistent with earlier studies and was considered manageable


AbbVie to acquire Apogee in $10.9 billion immunology power play
Biopharma | June 23, 2026

AbbVie to acquire Apogee in $10.9 billion immunology power play

Under the agreement, Apogee shareholders will receive $135.11 per share in cash, and the transaction has been unanimously approved by both companies’ boards


Suven Life Sciences to spotlight CNS pipeline & strike partnering deals at BIO-2026 San Diego
Biotech | June 23, 2026

Suven Life Sciences to spotlight CNS pipeline & strike partnering deals at BIO-2026 San Diego

The company plans an aggressive partnering push, with 62 pre-scheduled meetings over four days, focused on out-licensing, co-development, and strategic collaborations with global pharmaceutical and biotech players